Stocktoria
IMMUNIC, INC. IMUX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2014-04-17
IMMUNIC, INC. statistics & valuation
Market cap$208.4M
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -404.0% | -245.9% | -172.4% | -94.2% | -66.8% |
| Return on equity | 1456.2% | -545.4% | -323.6% | -105.9% | -73.1% |
| Current ratio | 0.75 | 1.77 | 2.12 | 9.62 | 9.21 |
Source: SEC EDGAR filings · CIK 0001280776 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.